| [1]Hoekstra R, Nibourg GA, van der Hoeven TV, et al. The HepaRG cell line is suitable for bioartificial liver application. Int J Biochem Cell Biol. 2011;43(10):1483-1489.[2]Pan XP, Li LJ. Advances in cell sources of hepatocytes for bioartificial liver. Hepatobiliary Pancreat Dis Int. 2012;11(6): 594-605.[3]Barakat O, Abbasi S, Rodriguez G, et al. Use of Decellularized Porcine Liver for Engineering Humanized Liver Organ. J Surg Res. 2012;173(1):e11-25. [4]Wu C, Pan J, Bao Z, et al. Fabrication and characterization of chitosan microcarrier for hepatocyte culture. J Mater Sci Mater Med. 2007;18(11):2211-2214.[5]Park Y, Subramanian K, Verfaillie CM, et al. Expansion and hepatic differentiation of rat multipotent adult progenitor cells in microcarrier suspension culture. J Biotechnol. 2010;150(1): 131-139. [6]Eibes G, dos Santos F, Andrade PZ, et al. Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. J Biotechnol. 2010; 146(4):194-197.[7]Rustad KC, Wong VW, Sorkin M, et al. Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold. Biomaterials. 2012;33(1): 80-90.[8]Bhardwaj N, Nguyen QT, Chen AC, et al. Potential of 3-D tissue constructs engineered from bovine chondrocytes/silk fibroin-chitosan for in vitro cartilage tissue engineering. Biomaterials. 2011;32(25):5773-5781. [9]Rigopoulou EI, Roggenbuck D, Smyk DS, et al. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev. 2012; 12(2): 260-269.[10]Selman L, Hansen S. Structure and function of collectin liver 1 (CL-L1) and collectin 11 (CL-11, CL-K1). Immunobiology. 2012;217(9):851-863.[11]Wen X, Peng X, Fu H, et al. Preparation and in vitro evaluation of silk fibroin microspheres produced by a novel ultra-fine particle processing system. Int J Pharm. 2011; 416(1):195-201. [12]Zheng D, Duan C, Zhang D, et al. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of Oridonin. Int J Pharm. 2012;436(1-2):379-386.[13]Li L, Qian Y, Jiang C, et al. The use of hyaluronan to regulate protein adsorption and cell infiltration in nanofibrous scaffolds. Biomaterials. 2012;33(12):3428-3445. [14]Park IK, Yang J, Jeong HJ, et al. galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment. Biomaterials. 2003;24(13):2331-2337.[15]Park TG. Perfusion culture of hepatocytes within galactose derivatized biodegradable poly (lactide-co-glycolide) scaffolds prepared by gas foaming of effervescent salts. J Biomed Mater Res. 2002;59(1):127-135.[16]Jin H J, Chen JS, Karageorgiou V, et al. Human bone marrow stromal cell responses on electrospun silk fibroin mats. Biomaterials. 2004;25(6):1039-1047.[17]Wu XB, Peng CH, Huang F, et al. Preparation and characterization of chitosan porous microcarriers for hepatocyte culture. Hepatobiliary Pancreat Dis Int. 2011; 10(5):509-515.[18]Duan B, Wang M, Zhou WY, et al. Three-dimensional nanocomposite scaffolds fabricated via selective laser sintering for bone tissue engineering. Acta Biomater. 2010; 6(12):4495-505. [19]Barakat O, Abbasi S, Rodriguez G, et al. Use of decellularized porcine liver for engineering humanized liver organ. J Surg Res. 2012;173(1):e11-25. [20]Wei X, Zhang Z, Qian Z, et al. Pharmacokinetics and in vivo fate of drug loaded chitosan nanoparticles. Curr Drug Metab. 2012;13(4):364-371.[21]Bhardwaj N, Kundu SC. Chondrogenic differentiation of rat MSCs on porous scaffolds of silk fibroin/chitosan blends. Biomaterials. 2012;33(10):2848-2857.[22]Wang Y, Bella E, Lee CS, et al. The synergistic effects of 3-D porous silk fibroin matrix scaffold properties and hydrodynamic environment in cartilage tissue regeneration. Biomaterials. 2010;31(17):4672-4681.[23]Wen X, Peng X, Fu H, et al. Preparation and in vitro evaluation of silk fibroin microspheres produced by a novel ultra-fine particle processing system. Int J Pharm. 2011; 16(1):195-201. [24]Lu Q, Huang Y, Li M, et al. Silk fibroin electrogelation mechanisms. Acta Biomater. 2011;7(6):2394-400. [25]Waldert M, Klatte T, Haitel A, et al. Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol. 2010;57(4):661-665. [26]Silva GA, Coutinho OP, Ducheyne P, et al. The efect of starch and starch-bioactive glass composite microparticles on the adhesion and expression of the osteoblastic phenotype of a bone cell line. Biomaterials. 2007;28(2):326-334. [27]Harada K, Mitaka T, Miyamoto S, et al. Rapid formation of hepatic organoid in collagen sponge by rat small hepatocytes and hepatic nonparenchymal cells. J Hepatol. 2003;39(5): 716-723.[28]Chung HJ, Kim IK, Kim TG, et al.Highly open porous biodegradable microcarriers: in vitro cultivation of chondrocytes for injectable delivery. Tissue Eng Part A. 2008;14(5):607-615.[29]Ohashi K, Yokoyama T, Yamato M, et al. Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat Med. 2007;13(7):880-885. |
.jpg)